Standard Biotools (LAB) FCF Margin Growth (1y) (2011 - 2026)
Standard Biotools (LAB) FCF Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | -473.00 |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn | 5,064.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,064.00 |
| Mar 31, 2026 | -4,712.00 |
| Dec 31, 2025 | 3,598.00 |
| Sep 30, 2025 | 3,539.00 |
| Jun 30, 2025 | 9,756.00 |
| Mar 31, 2025 | -3,584.00 |
| Dec 31, 2024 | -388.00 |
| Sep 30, 2024 | -10,015.00 |
| Jun 30, 2024 | -13,340.00 |
| Mar 31, 2024 | -10,110.00 |
| Dec 31, 2023 | 3,366.00 |
| Sep 30, 2023 | 5,234.00 |
| Jun 30, 2023 | 12,795.00 |
| Mar 31, 2023 | 2,430.00 |
| Sep 30, 2022 | -4,688.00 |
| Jun 30, 2022 | -10,412.00 |
| Mar 31, 2022 | -165.00 |
| Sep 30, 2021 | -4,162.00 |
| Jun 30, 2021 | -4,742.00 |
| Mar 31, 2021 | -4,117.00 |